BIOSPACE: “A Devil of a Disease”: The Current Alzheimer’s Pipeline

Chairman and co-founder of UsAgainstAlzheimer’s, George Vradenburg, on the current approaches to battling this disease.

LUNDBECK: Welcome to the New Era of Alzheimer’s Research

AD PACE founding sponsor, Lundbeck, explores how people with Alzheimer’s and care partners are shaping the future of drug development.

Brain Health Redux

UsA2 chairman and co-founder, George Vradenburg, reflects on the organization’s recent work and renews a call for a brain health check-up as a basic part of routine care.

FORBES: 3 New Alzheimer's Studies' Goal: 'Preparing Us For A Cure'

George Vradenburg, the co-founder and chairman of the UsAgainstAlzheimer’s advocacy group, is a man on a mission. And he is in a hurry.

UsAgainstAlzheimer’s Statement On Passage of AB 453 in California

Ensuring that all EMTs receive dementia training and guidance on how to best interact with and treat those living with cognitive impairment is a necessary step towards readying our entire healthcare system to improve the lives of those living with Alzheimer’s and dementia.

UsAgainstAlzheimer’s Research Highlights Opportunities to Prepare American Healthcare System for Alzheimer’s Cure

UsAgainstAlzheimer’s Releases “Preparing Us for a Cure,” Trio of Research Products Examining Ways to Ensure Alzheimer’s Treatments and a Cure Can Be Effectively Deployed

The Current Alzheimer’s Pipeline

New Era of Alzheimer’s Research

Brain Health Redux

Preparing Us For A Cure

Passage of AB 453 in California

UsAgainstAlzheimer’s is Helping Prepare Our System for a Cure

  • A Letter from Our Chairman

    UsAgainstAlzheimer’s Brain Health Partnership has issued a Call to Action white paper outlining recommendations for building a better system of care to promote brain health and fight back against Alzheimer’s.

Read the Letter

We Are Committed to Stopping Alzheimer's by 2025.

  • Blog Post
    Thumbnail

    “A Devil of a Disease”: The Current Alzheimer’s Pipeline

    This article was originally published by BioSpace on August 7, 2019.

    By Mark Terry

    As anyone following Alzheimer’s research knows, drug development for the disease has been a wasteland of failed

    Read more
  • My Birthday Wish

     

     

    My name is Andres Martin and this week I turned 32 years old.  I’m a proud father, husband, and veteran. Over the last couple of years, I’ve come

    Read more
  • Welcome to the New Era of Alzheimer’s Research: How People with Alzheimer’s and Care Partners are Shaping the Future of Drug Development

    This article was originally published by Lundbeck on July 17, 2019.

    By Mark Terry

    Leigh Callahan, PhD, is a respected epidemiologist and outcomes researcher who focuses on rheumatic disease. Her husband,

    Read more

The Pulse of the Community: Volume 3, Spring 2019

The A-LIST transforms the stories of more than 8,000 people living with Alzheimer’s or other dementias into evidence-based insights by providing unique, rapid-response, self-reported data through virtual surveys on what matters most on a wide range of Alzheimer’s-related topics. The A-LIST offers a powerful and validating voice for those living with Alzheimer’s and those caring for them, and a pathway to help expand treatments and accelerate toward a cure.